{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:03:54Z","timestamp":1776485034772,"version":"3.51.2"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>There are no formal guidelines for the management of patients with primary gastrointestinal (GI) cancers who have lung-exclusive or lung-predominant metastases. We performed a retrospective analysis to evaluate host and tumor characteristics of this patient population, model patterns and rates of growth, and describe treatment approaches.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>Eligible patients had a GI cancer with either synchronous or metachronous lung metastases but no other visceral or peritoneal sites of involvement. In addition to collecting detailed patient-specific and tumor-specific information, all imaging studies (computed tomography\u00b1positron emission tomography scans) were reviewed by an independent radiologist. Up to 5 lung metastases were tracked through each patient\u2019s clinical course. Growth rate was estimated using a linear mixed model analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Forty patients met eligibility criteria (18 pancreatic, 15 colorectal, 6 hepatobiliary, 1 gastroesophageal; synchronous vs. metachronous, 13 and 27, respectively). Median time from original cancer diagnosis to onset of metachronous lung lesions was 16 months. Interval from first appearance of lung metastases to treatment initiation was 6.2 months. Average growth rate of the largest lesion was 0.21\u2009mm\/mo (95% confidence interval, 0.12-0.30), with substantial intrapatient and interpatient variability. Sixty percent of patients underwent locoregional interventions in addition to or in lieu of systemic therapy for their lung metastases. Median survival of the entire study cohort from first appearance of lung metastases was 54 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Lung metastases from primary GI cancers have a variable but overall indolent natural history and are generally associated with prolonged survival outcomes. Further efforts to define patterns of growth of lung metastases, informed by size, number, and clinical\/molecular features, are needed to guide appropriate timing and selection of therapy as well as surveillance strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000879","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T17:03:36Z","timestamp":1638723816000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease"],"prefix":"10.1097","volume":"45","author":[{"given":"Shohei","family":"Burns","sequence":"first","affiliation":[{"name":"School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Vella","sequence":"additional","affiliation":[{"name":"Radiology and Biomedical Imaging"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Paciorek","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics"},{"name":"Helen Diller Family Comprehensive Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics"},{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe E.","family":"Atreya","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Feng","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Radiation Oncology, University of California, San Francisco, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin K.","family":"Kelley","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Tempero","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Van Loon","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Ko","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center"},{"name":"Division of Hematology and Oncology, Departments of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry","year":"2010","journal-title":"Gut"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","article-title":"Colorectal cancer: metastases to a single organ","volume":"21","author":"Vatandoust","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3748\/wjg.v23.i10.1872","article-title":"Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis","volume":"23","author":"Oweira","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/jcm8091402","article-title":"Lung metastases in patients with stage IV pancreatic cancer: prevalence, risk factors, and survival impact","volume":"8","author":"Liu","year":"2019","journal-title":"J Clin Med"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1080\/0284186X.2018.1487581","article-title":"The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern","volume":"57","author":"Prasanna","year":"2018","journal-title":"Acta Oncol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jso.23943","article-title":"The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas","volume":"112","author":"Downs-Canner","year":"2015","journal-title":"J Surg Oncol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/0284186X.2020.1837945","article-title":"Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort","volume":"60","author":"Rumpold","year":"2021","journal-title":"Acta Oncol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"e18191","DOI":"10.1097\/MD.0000000000018191","article-title":"Prognostic value of site-specific metastases for patients with advanced intrahepatic cholangiocarcinoma: A SEER database analysis","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.suronc.2019.08.010","article-title":"Oligometastatic pulmonary metastasis in pancreatic cancer patients: safety and outcome of resection","volume":"31","author":"Ilmer","year":"2019","journal-title":"Surg Oncol"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/s41598-020-61487-0","article-title":"Surgery for synchronous and metachronous single-organ metastasis of pancreatic cancer: a SEER database analysis and systematic literature review","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.pan.2019.05.466","article-title":"Surgical treatment of metastatic pancreatic ductal adenocarcinoma: a review of current literature","volume":"19","author":"Sakaguchi","year":"2019","journal-title":"Pancreatology"},{"key":"R12-20250527","first-page":"5573","article-title":"Surgical treatment for pulmonary metastasis of pancreatic ductal adenocarcinoma: study of 12 cases","volume":"37","author":"Yasukawa","year":"2017","journal-title":"Anticancer Res"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00595-019-01794-w","article-title":"Surgical outcomes of pulmonary metastasis from hepatopancreatobiliary carcinomas: a comparison with pulmonary metastasis from colorectal carcinomas","volume":"49","author":"Kaiho","year":"2019","journal-title":"Surg Today"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.21873\/anticanres.11464","article-title":"Surgical resection for pulmonary metastasis from pancreatic and biliary tract cancer","volume":"37","author":"Tagawa","year":"2017","journal-title":"Anticancer Res"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00268-015-3213-3","article-title":"Clinical significance of multiple pulmonary metastasectomy for hepatocellular carcinoma","volume":"40","author":"Mizuguchi","year":"2016","journal-title":"World J Surg"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/codi.15113","article-title":"Pulmonary metastasectomy in colorectal cancer: updated analysis of 93 randomized patients\u2014control survival is much better than previously assumed","volume":"22","author":"Milosevic","year":"2020","journal-title":"Colorectal Dis"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/codi.15651","article-title":"Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) Cohort Study: analysis of case selection, risk factors and survival in a prospective observational study of 512 patients","volume":"23","author":"Treasure","year":"2021","journal-title":"Colorectal Dis"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.athoracsur.2018.10.028","article-title":"Expert consensus document on pulmonary metastasectomy","volume":"107","author":"Handy","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"36566","DOI":"10.18632\/oncotarget.16616","article-title":"Post-pulmonary metastasectomy prognosis after curative resection for colorectal cancer","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12893-017-0252-8","article-title":"Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era","volume":"17","author":"Yokoyama","year":"2017","journal-title":"BMC Surg"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","article-title":"Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis","volume":"20","author":"Gonzalez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s13063-019-3837-y","article-title":"Pulmonary Metastasectomy versus Continued Active Monitoring in Colorectal Cancer (PulMiCC): a multicentre randomised clinical trial","volume":"20","author":"Treasure","year":"2019","journal-title":"Trials"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ans.16383","article-title":"Meta-analysis of survival outcomes following surgical and non surgical treatments for colorectal cancer metastasis to the lung","volume":"91","author":"Ratnayake","year":"2021","journal-title":"ANZ J Surg"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12885-019-5362-5","article-title":"The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases","volume":"19","author":"Klement","year":"2019","journal-title":"BMC Cancer"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.radonc.2018.10.024","article-title":"Predictive factors for survival of oligometastatic colorectal cancer treated with stereotactic body radiation therapy","volume":"133","author":"Franzese","year":"2019","journal-title":"Radiother Oncol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1186\/s12885-020-07514-9","article-title":"Analyses of the local control of pulmonary oligometastases after stereotactic body radiotherapy and the impact of local control on survival","volume":"20","author":"Yamamoto","year":"2020","journal-title":"BMC Cancer"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.radonc.2019.10.004","article-title":"Prognostic factors for local control and survival for inoperable pulmonary colorectal oligometastases treated with stereotactic body radiotherapy","volume":"144","author":"Sharma","year":"2020","journal-title":"Radiother Oncol"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.21037\/jtd.2019.12.12","article-title":"A systematic review and meta-analysis of stereotactic body radiation therapy for colorectal pulmonary metastases","volume":"11","author":"Cao","year":"2019","journal-title":"J Thorac Dis"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:07:27Z","timestamp":1748365647000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000879"}},"subtitle":["A Retrospective Cohort Analysis"],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000879","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,6]]}}}